Sabra Healthcare Reit Stock Analysis

SBRA Stock  USD 18.91  0.07  0.37%   
Sabra Healthcare REIT is overvalued with Real Value of 15.07 and Target Price of 14.63. The main objective of Sabra Healthcare stock analysis is to determine its intrinsic value, which is an estimate of what Sabra Healthcare REIT is worth, separate from its market price. There are two main types of Sabra Healthcare's stock analysis: fundamental analysis and technical analysis.
The Sabra Healthcare stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Sabra Healthcare's ongoing operational relationships across important fundamental and technical indicators.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sabra Healthcare REIT. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Sabra Stock Analysis Notes

About 99.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.6. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Sabra Healthcare REIT last dividend was issued on the 15th of November 2024. The entity had 1:3 split on the 16th of November 2010. As of March 31, 2022, Sabras investment portfolio included 416 real estate properties held for investment. As of March 31, 2022, Sabras real estate properties held for investment included 41,445 bedsunits, spread across the United States and Canada. Sabra REIT operates under REITHealthcare Facilities classification in the United States and is traded on NASDAQ Exchange. It employs 42 people. To find out more about Sabra Healthcare REIT contact Richard Matros at 888 393 8248 or learn more at https://www.sabrahealth.com.

Sabra Healthcare Quarterly Total Revenue

94.56 Million

Sabra Healthcare REIT Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Sabra Healthcare's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Sabra Healthcare REIT or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Sabra Healthcare REIT currently holds 2.45 B in liabilities with Debt to Equity (D/E) ratio of 0.76, which is about average as compared to similar companies. Sabra Healthcare REIT has a current ratio of 0.76, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Sabra Healthcare's use of debt, we should always consider it together with its cash and equity.
Sabra Healthcare has a poor financial position based on the latest SEC disclosures
Over 99.0% of Sabra Healthcare shares are owned by institutional investors
Latest headline from MacroaxisInsider: Disposition of 2291 shares by Jessica Flores of Sabra Healthcare at 13.99 subject to Rule 16b-3

Sabra Healthcare REIT Upcoming and Recent Events

Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Sabra Healthcare previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
20th of February 2024
Upcoming Quarterly Report
View
1st of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
20th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Sabra Largest EPS Surprises

Earnings surprises can significantly impact Sabra Healthcare's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2023-08-07
2023-06-300.10.09-0.0110 
2011-11-02
2011-09-300.080.07-0.0112 
2011-08-02
2011-06-300.090.08-0.0111 
View All Earnings Estimates

Sabra Healthcare Environmental, Social, and Governance (ESG) Scores

Sabra Healthcare's ESG score is a quantitative measure that evaluates Sabra Healthcare's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Sabra Healthcare's operations that may have significant financial implications and affect Sabra Healthcare's stock price as well as guide investors towards more socially responsible investments.

Sabra Healthcare Thematic Classifications

In addition to having Sabra Healthcare stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Investing Idea
Investing
Money and asset management including investment banking

Sabra Stock Institutional Investors

Shares
Dimensional Fund Advisors, Inc.2024-09-30
3.4 M
Deutsche Bank Ag2024-06-30
3.3 M
Northern Trust Corp2024-09-30
3.3 M
Jpmorgan Chase & Co2024-06-30
3.1 M
Norges Bank2024-06-30
2.8 M
Apg Investments Us Inc2024-06-30
2.6 M
Systematic Financial Management Lp2024-09-30
2.3 M
Duff & Phelps Inv Mgmt Co (il)2024-06-30
M
Advisors Capital Management, Llc2024-09-30
1.9 M
Vanguard Group Inc2024-09-30
34.9 M
Blackrock Inc2024-06-30
34.4 M
Note, although Sabra Healthcare's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Sabra Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 4.46 B.

Sabra Profitablity

The company has Profit Margin (PM) of 0.14 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.36 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.36.
Last ReportedProjected for Next Year
Return On Capital Employed 0.04  0.05 

Management Efficiency

Sabra Healthcare REIT has return on total asset (ROA) of 0.0283 % which means that it generated a profit of $0.0283 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0346 %, meaning that it created $0.0346 on every $100 dollars invested by stockholders. Sabra Healthcare's management efficiency ratios could be used to measure how well Sabra Healthcare manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Capital Employed is expected to grow to 0.05, whereas Return On Tangible Assets are forecasted to decline to 0. At present, Sabra Healthcare's Other Assets are projected to increase significantly based on the last few years of reporting. The current year's Total Current Assets is expected to grow to about 387.9 M, whereas Total Assets are forecasted to decline to about 4.2 B.
Last ReportedProjected for Next Year
Book Value Per Share 12.12  12.46 
Tangible Book Value Per Share 11.99  12.22 
Enterprise Value Over EBITDA 18.30  29.83 
Price Book Value Ratio 1.18  1.53 
Enterprise Value Multiple 18.30  29.83 
Price Fair Value 1.18  1.53 
Enterprise Value5.7 B3.2 B
The strategic initiatives led by Sabra Healthcare's management are central to its market success. By analyzing these initiatives, we provide a clear picture of the stock's growth prospects.
Dividend Yield
0.0648
Operating Margin
0.3632
Profit Margin
0.1422
Forward Dividend Yield
0.0648
Beta
1.235

Technical Drivers

As of the 28th of November, Sabra Healthcare has the Risk Adjusted Performance of 0.1196, semi deviation of 1.56, and Coefficient Of Variation of 668.07. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Sabra Healthcare REIT, as well as the relationship between them.

Sabra Healthcare REIT Price Movement Analysis

Execute Study
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Sabra Healthcare middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Sabra Healthcare REIT. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Sabra Healthcare REIT Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Sabra Healthcare insiders, such as employees or executives, is commonly permitted as long as it does not rely on Sabra Healthcare's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Sabra Healthcare insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Jessica Flores 2 days ago
Disposition of 2291 shares by Jessica Flores of Sabra Healthcare at 13.99 subject to Rule 16b-3
 
Richard Matros over two months ago
Acquisition by Richard Matros of 12412 shares of Sabra Healthcare subject to Rule 16b-3
 
Foster Michael J over two months ago
Acquisition by Foster Michael J of 1011 shares of Sabra Healthcare subject to Rule 16b-3
 
Barbarosh Craig A. over three months ago
Acquisition by Barbarosh Craig A. of 9480 shares of Sabra Healthcare subject to Rule 16b-3
 
Michael Costa over three months ago
Acquisition by Michael Costa of 3004 shares of Sabra Healthcare subject to Rule 16b-3
 
Richard Matros over six months ago
Acquisition by Richard Matros of 13923 shares of Sabra Healthcare subject to Rule 16b-3
 
Cusack Catherine over six months ago
Acquisition by Cusack Catherine of 7000 shares of Sabra Healthcare at 14.43 subject to Rule 16b-3
 
Foster Michael J over six months ago
Disposition of 10000 shares by Foster Michael J of Sabra Healthcare at 14.683 subject to Rule 16b-3
 
Porter Clifton J Ii over six months ago
Acquisition by Porter Clifton J Ii of 473 shares of Sabra Healthcare subject to Rule 16b-3
 
Craig Barbarosh over six months ago
Acquisition by Craig Barbarosh of 1101 shares of Sabra Healthcare subject to Rule 16b-3
 
Porter Clifton J Ii over six months ago
Acquisition by Porter Clifton J Ii of 570 shares of Sabra Healthcare subject to Rule 16b-3
 
Michael Costa over six months ago
Disposition of 5151 shares by Michael Costa of Sabra Healthcare at 11.8 subject to Rule 16b-3

Sabra Healthcare Outstanding Bonds

Sabra Healthcare issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Sabra Healthcare REIT uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Sabra bonds can be classified according to their maturity, which is the date when Sabra Healthcare REIT has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Sabra Healthcare Predictive Daily Indicators

Sabra Healthcare intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Sabra Healthcare stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Sabra Healthcare Corporate Filings

8K
12th of November 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
8K
31st of October 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
13A
18th of October 2024
An amended filing to the original Schedule 13G
ViewVerify
F4
19th of September 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F4
4th of September 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
8K
7th of August 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
F4
17th of June 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
8K
13th of June 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify

Sabra Healthcare Forecast Models

Sabra Healthcare's time-series forecasting models are one of many Sabra Healthcare's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Sabra Healthcare's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Sabra Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Sabra Healthcare prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Sabra shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Sabra Healthcare. By using and applying Sabra Stock analysis, traders can create a robust methodology for identifying Sabra entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin 0.02  0.02 
Operating Profit Margin 0.34  0.47 
Net Profit Margin 0.02  0.02 
Gross Profit Margin 0.42  0.39 

Current Sabra Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Sabra analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Sabra analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
14.63Strong Buy14Odds
Sabra Healthcare REIT current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Sabra analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Sabra stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Sabra Healthcare REIT, talking to its executives and customers, or listening to Sabra conference calls.
Sabra Analyst Advice Details

Sabra Stock Analysis Indicators

Sabra Healthcare REIT stock analysis indicators help investors evaluate how Sabra Healthcare stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Sabra Healthcare shares will generate the highest return on investment. By understating and applying Sabra Healthcare stock analysis, traders can identify Sabra Healthcare position entry and exit signals to maximize returns.
Begin Period Cash Flow53.9 M
Long Term Debt2.3 B
Common Stock Shares Outstanding232.8 M
Total Stockholder Equity2.8 B
Tax ProvisionM
Quarterly Earnings Growth Y O Y0.111
Property Plant And Equipment Net4.6 B
Cash And Short Term Investments46.7 M
Cash41.3 M
Accounts Payable73.8 M
Net Debt2.4 B
50 Day M A18.6298
Total Current Liabilities1.8 B
Other Operating Expenses420.8 M
Non Current Assets Total30.9 M
Forward Price Earnings8.7108
Non Currrent Assets Other-213.6 M
Stock Based Compensation7.9 M

Complementary Tools for Sabra Stock analysis

When running Sabra Healthcare's price analysis, check to measure Sabra Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sabra Healthcare is operating at the current time. Most of Sabra Healthcare's value examination focuses on studying past and present price action to predict the probability of Sabra Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sabra Healthcare's price. Additionally, you may evaluate how the addition of Sabra Healthcare to your portfolios can decrease your overall portfolio volatility.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Fundamental Analysis
View fundamental data based on most recent published financial statements
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Global Correlations
Find global opportunities by holding instruments from different markets